title: Classification of two steroids, prostanozol and methasterone, as Schedule III anabolic steroids under the Controlled Substance Act. Final rule.
abstract: With the issuance of this Final Rule, the Administrator of the DEA classifies the following two steroids as "anabolic steroids'' under the Controlled Substances Act (CSA): prostanozol (17[beta]-hydroxy-5[alpha]-androstano[3,2-c]pyrazole) and methasterone (2[alpha],17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one). These steroids and their salts, esters, and ethers are Schedule III controlled substances subject to the regulatory control provisions of the CSA.
mesh_terms: D045930:Anabolic Agents / Q000145:classification*; D000732:Androstanols / Q000145:classification*; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D004349:Drug Packaging / Q000331:legislation & jurisprudence; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D013256:Steroids / Q000145:classification*; D014481:United States
chemical_list: D045930:Anabolic Agents; D000732:Androstanols; D013256:Steroids